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ABSTRACT 
This article illustrates the Formulation and Characterization of Mucoadhesive microspheres of Gliclazide Hydrochloride. The 
mucoadhesive microspheres were prepared by the Emulsion Solvent Evaporation method by using Eudragit L 100 and Ethyl 
Cellulose 22 CPS polymers & PEG 4000 added as a pore forming agent . Formulated microspheres were evaluated for various 
parameters. The characteristics like shape and structure of prepared microspheres were determined by Optical microscopy and 
scanning electron microscopy respectively. The prepared microspheres exhibited prolonged drug release (12 hrs) the mean particle 
size increased as the concentration of Eudragit L 100 increased. Decrease in size of microspheres leads to decrease in mucoadhesion 
time, % drug loading and faster the drug release. The optimized formulation shows following cumulative release after 12 hrs i.e. 
96.40%. The microspheres exhibited 80% mucoadhesion and showed good drug entrapment efficiency i.e. 80.13±0.91% as well as 
drug loading efficiency is 26.70±0.75%.  It can be concluded that the present mucoadhesive microspheres can be an ideal system to 
deliver the Gliclazide Hydrochloride in the sustained release manner for management of Type II Diabetes Mellitus.  
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INTRODUCTION
1,2,3 
Oral route of administration is much important to the 
conscious patient because the most of the dosage form 
having shot duration of action. The success of normal 
microspheres is limited due to short residence time at the 
site of absorption. The mucoadhesive microspheres 
would be benefited to provide a good contact of drug 
delivery system with absorbing membrane. They can be 
achieved by coupling bio-adhesion properties to 
microspheres and to formulating bio-adhesive 
microspheres. 
The term microsphere is defined as a spherical particle 
with size from 1 um -1000um. The microsphere are 
typical free flowing powder consist of synthetic polymer 
which are Biod E.g. radable in nature and having particle 
size less than 200 um. The microspheres are made from 
highly transparent glass can perform as much high 
quality optical micro cavities or micro resonators. The 
success of these microspheres is limited having provided 
intimate contact of the drug delivery system with the 
absorbing membranes.
4,5 
MATERIALS AND METHODS 
Materials:  
Gliclazide hydrochloride was obtained as gift sample 
from M/s Flamingo Pharmaceutical Private Limited, 
Nanded.  Ethyl cellulose 22 CPS, Eudragit L 100, Poly 
Vinyl Alcohol Hot, Dichloro Methane, Methanol and 
Conc. Hydrochloric acid purchased from Research-Lab 
Fine Chemical Industries. Mumbai.  The entire 
chemicals were of analytical grade and double distilled 
water used throughout the experiment. 
Methods:  
Formulation of Mucoadhesive Microspheres of 
Gliclazide 
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Mucoadhesive Microsphere containing Gliclazide was 
prepared using Emulsion solvent evaporation method. 
The drug to polymer ratio used to prepare the different 
formulations was 1:2. The polymer content was a 
mixture of Eudragit L-100 and Ethyl Cellulose 22cps in 
varying concentration & PEG 4000. The drug polymer 
mixture was dissolved in a mixture of Dichloromethane 
and Methanol (1:1v/v). The mixture was dropped in to 
0.4%
w/v
 Polyvinyl alcohol solution (400ml) containing 
mag. stearate by 22 gauge needle. The solution was 
stirred with a propeller-type agitator and magnetic stirrer 
at 40 C for 1 h at 300 rpm. The formed mucoadhesive 
microspheres were filtered by whattmann filter paper 
washed with water and dried at 40
oC
 overnight. 
 
Table 1: Formulated batches of microspheres 
Batches 
Codes 
Drug : Polymer (1:2) PVA Solution 
(% w/v) 
Mag. Stearate 
(% w/v) 
PEG 4000 
(% w/v) Drug (mg) Eudragit L100 
(mg) 
Ethyl Cellulose 
22cps (mg) 
B1 300 485 115 0.4 0.1 0.5 
B2 300 400 200 0.4 0.1 0.5 
B3 300 300 300 0.4 0.1 0.5 
B4 300 200 400 0.4 0.1 0.5 
B5 300 100 500 0.4 0.1 0.5 
B6 300 450 150 0.4 0.1 0.5 
B7 300 500 100 0.4 0.1 0.5 
B8 300 475 125 0.4 0.1 0.5 
 
Evaluation of Microspheres 
1) FT-IR
7,8 
FT-IR spectra for pure Gliclazide Hydrochloride and 
Different polymers acquired at room temperature using 
FT-IR spectrophotometer (FTIR-8400S, Shimadzu, 
Japan) in transmittance mode. The samples were ground 
in a mortar, mixed with Nujol and placed between two 
plates of KBr and compressed to form a thin film. The 
sandwiched plates were placed in the infrared 
spectrometer and the spectra were obtained. Scanning 
was performed between wave numbers 4000-400 cm
-1 
2) Differential scanning colorimetry analysis
9,10
 
Method for estimating the physical interaction between 
drug and polymers used for the formulation of different 
dosage form is thermal analysis by DSC. In the present 
studies the DSC analysis of Gliclazide Hydrochloride 
hydrochloride, and ethyl cellulose with Eudragit L 100 
for preparation of muco-adhesive microsphere (B1-B8) 
were carried out using a Shimadzu DSC 60, Japan; to 
evaluate any possible polymer drug thermal interaction. 
Exactly weighed 5 to 6 mg samples were hermetically 
sealed in aluminium crucible and heated at constant rate 
of 10
o
C/min over a temperature range of 40 to 300
o
C. 
Inert atmosphere was maintained by purging nitrogen 
gas at a flow rate of 50 ml/min. 
3) Nature of particles
11
 
The smooth surface of particle improves the flow. The 
particle having high density and low internal porosity 
tend to process good flow properties. Flate and 
elongated particle tend to pack loosely and give high 
porosity. The generation of electrical charge by friction 
between two particles during the movement also lead to 
cohesion. 
4) Percentage Practical yield
12
 
The percentage yield is athe percentage ratio of actual 
yield to theoretical yield.  The measured weight was 
divided by total amount of all non-volatile components 
which were used for the preparation of microsphere. 
Percentage yield can be calculated using the formula, 
                  
                   
                          
     
5) Particle size
 13 
The most widely used procedures to visualize 
microparticles are conventional light microscopy (LM) 
and scanning electron microscopy (SEM). Samples of 
the microparticles were analyzed for particle size by 
optical microscope. The instrument was calibrated and 
found that 1unit of eyepiece micrometer was equal to 
12.5μm. Nearly about 100 Microparticles sizes were 
calculated under 45 x magnifications. The microsphere 
size distribution was determined by the optical 
microscopy method using a calibrated stage micrometer 
(μm) and size was calculated by using equation. 
Xg = 10 x [(ni x log Xi) / N] 
Xg is geometric mean diameter, ni is number of particle 
in range, xi is the midpoint of range and N is the total 
number of particles. All the experimental units were 
analyzed in triplicate. 
6) Density determination
14 
The density of microsphere is measured by using a multi 
volume psychomotor. Exact weight sample in a cup is 
placed into the multi volume psychomotor. The helium 
is come the contact pressure in the chamber and allowed 
expand. These expansion results are to minimize 
pressure within the chamber. The two successive reading 
of reduce pressure at different first pressure are noted. 
From two pressures reading the density of the 
microsphere carrier is determined.        
1) Tapped density
15,16 
Accurately weighed quantity of powder is introduced 
into a measuring cylinder. Mechanically tap the cylinder 
containing the sample by raising the cylinder and 
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allowing it to drop under its own weight using a suitable 
mechanical tapped density tester at a nominal rate of 300 
drops/min. Tap the cylinder 500 times and measure the 
tapped volume (Va). Repeat the operation for an 
additional 750 tappings and again measure the tapped 
volume as (Vb). If the difference between Va and Vb is 
<2%, Vb is the final tapped volume (Vf). If the 
difference is higher, repeat the tapings for an additional 
1,250 times, and then the tapped density can be 
calculated using the following formula 
              
    
             
     
2) Bulk density
17,18 
The bulk density depends on particle size, shape and 
cohesiveness of particle. Unless otherwise specified, 
pass a quantity of material sufficient to complete the test 
through a 1.00-mm (no. 18) screen to break up 
agglomerates that may have formed during storage. Into 
a dry 250-ml cylinder introduce, without compacting, 
approximately 100 g of the test sample (M) weighed 
with 0.1% accuracy. If it is not possible to use 100 g, the 
amount of the test sample and the volume of the cylinder 
may be modified. Select a sample mass having an 
untapped apparent volume of 150–250 ml. A 100-ml 
cylinder is used for apparent volumes between 50 and 
100 ml. Fill the cylinder carefully. Carefully level the 
powder without compacting, if necessary, and read the 
unsettled apparent volume (Vo). Calculate the bulk 
density, in g/ml, using the formula, 
            
     
           
     
Bulk density is used to check the uniformity if bulk 
chemical. The size of capsule is mainly determined by 
bulk volume for given dose of material. 
7) Flow properties  
1) Angle of repose
19 
It is determined by allowing a powder to flow through a 
funnel and fall freely on to a surface. Further addition of 
powder is stopped as soon as the pile touches the tip of 
the funnel. A circle is drawn around the pile without 
disturbing it. The height and diameter of the resulting 
cone are measured. The same procedure is repeated three 
times and the average value is taken. Angle of repose is 
calculated by using the following equation: 
θ = Tan-1 h/r 
Where, h = height of the powder cone; r = radius of the 
powder 
2) Hausner Ratio
20 
The Hausner ratio can be determined using the following 
formula: 
              
              
           
     
3) Carr’s index21 
The compressibility index of granules can be determined 
using Carr’s compressibility index, and can be 
determined by the following formula: 
             
             
           
     
8) Drug entrapment efficiency
22
 
 The microspheres containing drug were compressed and 
then dissolve in small amount of methanol & then in 
distilled water with the help of ultrasonic stirrer for three 
hours. Than it filtered and assay by ultra violet radiation 
spectroscopy. The entrapment of efficiency is equal to 
ratio of real drug content to theoretical drug content.  
     
                     
                       
     
9) Drug loading efficiency
23 
The entrapment efficiency refers actually to the 
capability of the drug to be entrapped while 
the loading capacity is actually the ability of the material 
to entrap a certain active substance Loading= (weight 
of drug in nanoparticles*100)/weight of microspheres 
that are obtained after the manufacture procedure. 
A loading dose is an initial higher dose of a drug that 
may be given at the beginning of a course of treatment 
before dropping down to a lower maintenance dose. A 
loading dose is most useful for drugs that are eliminated 
from the body relatively slowly, i.e. have a long 
systemic half-life. 
     
                     
                          
     
10) In-vitro mucoadhesive study
24 
Take a 2 cm wide and 2 cm long (2×2) piece of sheep 
intestinal mucosa was tied onto a glass slide using 
thread. About 50mg microspheres were spread onto the 
wet, rinsed, tissue specimen, and allowed to hydrate for 
5 min. The prepared slide was hung onto one of the 
grooves of a USP tablet disintegrating test apparatus. 
The disintegrating test apparatus was operated such that 
the tissue specimen was given regular up and down 
movements in the test fluid (900ml) at 37 °C contained 
in one liter vessel of the machine. At the end of 1 h, the 
machine was stopped and the number of microspheres 
still adhering to the tissue was counted. The test was 
performed at gastric pH 0.1 N HCl. 
               
                  
                          
     
11) Scanning electron microscopy
25 
Shape and surface characteristic of hollow microspheres 
examine by Scanning Electronic Microscopy analysis as 
shown in Fig. no. 10 and 11. Surface morphology of B7 
formulation examine at to different magnification 40X 
and 200X, which illustrate the smooth surface of 
mucoadhesive microspheres and small hollow cavity 
present in microsphere which is responsible for 
mucoadhesive property. 
12) In vitro drug release
26,27 
In vitro drug release study was carried out in USP XXI 
paddle type dissolution test apparatus using acidic buffer 
pH 1.2 as dissolution medium, volume of dissolution 
medium was 900 ml and bath temperature was 
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maintained at (37±1)°C throughout the study. Release 
studies for different type of microspheres are carried out 
by using different suitable dissolution media, mostly by 
rotating paddle apparatus.  Paddle speed was adjusted to 
50 rpm. An interval of 1 hour, one ml of sample was 
withdrawn with replacement of one ml fresh medium. 
All the experimental units were analyzed in triplicate by 
UV. 
13) Stability study
28,29 
The placing of microspheres in screw capped glass 
container and stored them at 40
0
c and 75%Rh. The 
stability study carried out in 3 month and drug content 
was analyzed. 
RESULTS AND DISSCUSSION 
1) FT-IR
 
FT-IR Spectra were obtained for Gliclazide, physical 
mixture of and physical mixture of Gliclazide as shown 
in fig. no.1,5 , the characteristic peaks of the Gliclazide 
were compared with the peaks obtained for physical 
mixture of Gliclazide and polymer. 
 
 
Figure 1: FT-IR Spectra of Pure Gliclazide 
 
Figure 2:  FT-IR Spectra of Gliclazide & Eudragit L100 
 
Figure 3: FT-IR Spectra of Gliclazide & Ethyl Cellulose 
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Figure 4: FT-IR Spectra of Eudragit L100 & Ethyl Cellulose 
 
Figure 5: FT-IR Spectra of Gliclazide, Eudragit L100 & Ethyl Cellulose 
FT-IR obtained for pure Gliclazide, Gliclazide-Eudragit 
RS100, Gliclazide-Ethyl Cellulose and Gliclazide-
Eudragit L100 & Ethyl Cellulose there was no chemical 
interaction between Gliclazide and polymer and it can 
be concluded that the characteristics bands of Gliclazide 
were not affected after successful loading. 
2) Differential Scanning Colorimetric
 
 
Figure 6: DSC of Pure Drug Gliclazide 
           
  Figure 7: DSC of drug and polymers mixture 
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The DSC obtained for there was no interaction between 
the Gliclazide and the polymer in the solid state. The 
melting point range of Gliclazide is between 167-207°C, 
thus indicating there is no change of Gliclazide in pure 
state, physical mixture of drug and polymer. 
3) Particle size analysis
 
Particle size was determined by optical microscopy 
method. It plays an important role in mucoadhesive 
ability and release of drug from microspheres. If size of 
microspheres is less then release rate of drug will be 
high and mucoadhesive ability will reduce, white 
microspheres size is more, then mucoadhesive ability 
will be more and release rate will be in sustained 
manner. The mean particle size of hollow microsphere 
was in range 214.56±0.58 to 463.92±0.06 µm as shown 
in table 2. 
4) Determination of % practical yield of main batch
 
Percentage yield of different formulation was 
determined by weighing the microballoons after drying. 
The percentage yield of different formulation was in 
range of 65 -85% as shown in table 3 
 
 
Table 2: Particle size of batch B1-B8 
Batch Size (µm) 
B1 371.25±0.61 
B2 390.00±0.01 
B3 369.29±0.99 
B4 214.56±0.58 
B5 295.46±0.02 
B6 402.36±0.01 
B7 463.92±0.06 
B8 435.09±0.025 
 
Table 3: %Practical yield B1-B8 
Batch %Practical Yield 
B1 80.33 
B2 82.00 
B3 79.11 
B4 67.77 
B5 65.00 
B6 83.33 
B7 85.00 
B8 84.22 
 
5) Density calculation 
Table 4: Density of batch B1-B8 microspheres 
Batches 
Bulk density 
(g/cm
3
) 
Tapped density 
(g/cm
3
) 
Hausner’s 
ratio 
Result 
% Carr’s 
Index 
Result 
B1 0.0794±0.002 0.0881±0.002 1.10±0.10 Excellent 09.87±0.18 Excellent 
B2 0.0785±0.000 0.0911±0.001 1.16±0.02 Good 13.83±0.35 Good 
B3 0.0827±0.002 0.0975±0.002 1.17±0.02 Good 15.17±0.10 Good 
B4 0.0847±0.000 0.0983±0.001 1.16±0.02 Poor 13.83±0.20 Good 
B5 0.0835±0.001 0.0943±0.001 1.12±0.02 Fair 11.45±0.22 Good 
B6 0.0797±0.000 0.0872±0.001 1.09±0.02 Excellent 08.60±0.37 Excellent 
B7 0.0780±0.001 0.0840±0.001 1.07±0.02 Excellent 07.14±0.06 Excellent 
B8 0.0797±0.001 0.0871±0.001 1.09±0.02 Excellent 08.49±0.09 Excellent 
 
 
6) Angle of repose 
Table 5: Angle of repose of B1-B8 
Batches Angle of repose Result 
B1 27.02±0.98 Excellent 
B2 28.81±0.85 Excellent 
B3 33.82±1.14 Good 
B4 33.02±1.01 Good 
B5 29.24±1.24 Excellent 
B6 27.92±1.02 Excellent 
B7 27.47±0.77 Excellent 
B8 29.24±0.55 Excellent 
 
7) Drug entrapment efficiency
 
The drug entrapment efficacies of different formulations 
were in range of 62.84±0.82 to 80.13±0.91% w/w as 
shown in following table. Drug entrapment efficacy 
slightly decrease with increase Ethyl cellulose content 
and decreased Eudragit L100 ratio in microspheres. 
Table 6: %DEE of batch B1-B8 
Batch %DEE 
B1 72.14±0.02 
B2 70.82±0.19 
B3 66.92±1.94 
B4 65.54±0.42 
B5 62.84±0.82 
B6 75.33±0.91 
B7 80.13±0.91 
B8 78.75±0.55 
 
8) Drug Loading efficiency
 
The drug loading efficiencies of microspheres were in 
the range of 21.84±0.74 to 26.70±75% w/w as shown in 
following table: 
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Table 7: %DLE of batch B1-B8 
Batch %DLE 
B1 24.04±0.94 
B2 23.60±0.86 
B3 22.30±0.20 
B4 21.84±0.74 
B5 20.94±0.99 
B6 25.10±1.03 
B7 26.70±0.75 
B8 26.24±0.97 
 
9) Percentage Mucoadhesive test
 
The ability of mucoadhesion of different formulation 
were found to be differed according to Eudragit L100 
and Ethyl cellulose ratio. B1, B6, B7 & B8 formulations 
showed best mucoadhesive ability in 1 hours. B2, B3, 
B4 &B5 formulation showed less mucoadhesive ability 
as showed in following table. The mucoadhesive ability 
of microsphere is decreased by increasing the Ethyl 
cellulose ratio. 
Table 8: % Mucoadhesion test of B1-B8 
Batches % Mucoadhesion after 1 Hrs 
B1 70±1.37 
B2 56±1.00 
B3 50±2.64 
B4 46±3.00 
B5 44±2.00 
B6 74±2.64 
B7 80±2.64 
B8 80±1.73 
 
10) Scanning electron microscopy 
 
Figure 8: SEM of B7 
11) In-vitro drug release
 
The In-vitro drug release was performed using paddle 
type dissolution apparatus. In this method, a weighed 
quantity of the microsphere which is equal to dose is 
placed in muslin cloth and tie to the paddle. The 
dissolution study performed using 900ml 0.1 N HCl (pH 
1.2) for 12 Hrs at 37±0.5 
o
C stirred 50rpm. The 
mucoadhesive microspheres release the drug 86.65 to 
96.40 % from batch B1 –B8 & PEG400  also affects in 
vitro drug release. 
 
Figure 9: %DR of B1, B2, B3, B4 & B5 
 
 
Figure 10:  %DR of B1, B6, B7 & B8 
The in vitro performance of Gliclazide mucoadhesive 
microspheres showed sustained release of Gliclazide. 
The results of the In-vitro dissolution studies show as 
Ethyl Cellulose 22cps concentration increases the drug 
release from the mucoadhesive microsphere decreases. 
In-vitro drug release was found in the range of 86.65% 
to 96.40% over the 12 hrs.  
 
12) Release kinetic 
Table 9: Release kinetic of B7 
Formulation code 
Higuchi Zero Order First Order Hixoncrowell Korsemeyer-Peppas 
r
2 
r
2
 r
2
 r
2
 r
2
 N 
B7 0.94 0.96 0.88 0.93 0.93 1.33 
 
0 
20 
40 
60 
80 
100 
120 
0 2 4 6 8 10 12 14 
%
 D
R
U
G
 R
EL
EA
SE
 
TIME IN HOURS 
B1 
B2 
B3 
B4 
B5 
0 
20 
40 
60 
80 
100 
120 
0 2 4 6 8 10 12 14 
%
 D
R
U
G
 R
EL
EA
SE
 
TIME IN HOURS 
B1 
B6 
B7 
B8 
Shaikh et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2018; 8(4):117-125           
ISSN: 2250-1177                                                                             [124]                                                                             CODEN (USA): JDDTAO 
Drug release pattern was evaluated in 0.1 N HCl of B7 
formulation. Kinetics and mechanism of drug release 
from B7 formulation was evaluated on the basis of 
Higuchi equation, Zero order, First order, Hixon-crowell 
equation and Peppas model. Correlation coefficient (r2) 
and slope value for each equation in the range of (r2= 
0.83to 0.984 and n=0.11-42.92) was calculated.  
The diffusion exponent ‘n’ values of Korsemeyer-
Peppas model was found to be in the range of 1.33 for 
the Gliclazide mucoadhesive microspheres prepared 
with Eudragit L100 and EC22cps indicating Super Case 
II transport of drug through Gliclazide mucoadhesive 
microspheres.
 
13) Stability study 
Table 10: Results of stability study of B7 
Sr. no. Parameters evaluated Before stability After stability 
01. %DEE 80.13±0.91 78.14±0.12 
02. %DR 96.40 91.59 
 
 
Figure 16: Comparison of %DR of B7 before &after 
stability study 
 Stability studies 
The stability study of B7 batch was performed at 40
oC 
and 95.38% Rh for 3 months. After performing the 
dissolution of B7 batch after 3 months the percentage 
drug release was found to be 91.59%. It has been 
observe that there is no significant difference in 
percentage drug release and %DEE after stability study. 
CONCLUSION 
By studying all the experimental results it was 
conclusively demonstrated that Gliclazide 
Hydrochloride Mucoahesive microspheres loaded with 
macromolecular Mucoahesive polymers can be 
successfully formulated by emulsification solvent 
evaporation method. Among eight formulations, four 
formulations were found to be spherical and free 
flowing. The ratio of Eudragit L 100 and Ethyl 
Cellulose 22CPS at 1:2 and 1:1, were found to be 
optimum for the formulation of mucoadhesive 
microsphere. B1, B6 and B8 possessed the best results 
among all the formulations in terms of surface 
smoothness and shape. Therefore, Eudragit L 100 and 
Ethyl Cellulose 22CPS can be considered as promising 
materials for designing Gliclazide Hydrochloride 
mucoadhesive microspheres. The best cumulative 
release was achieved after 12 hrs i.e. 96.40%. PEG400 
also affects in vitro drug release. The microspheres 
exhibited 80% mucoadhesion and showed good drug 
entrapment efficiency i.e. 80.13±0.91% as well as drug 
loading efficiency is 26.70±0.75%. 
It can be concluded that the present mucoadhesive 
microspheres can be an ideal system to deliver the 
Gliclazide Hydrochloride in the sustained release 
manner for management of Type II Diabetes Mellitus. 
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